A population pharmacokinetic model that describes multiple peaks due to enterohepatic recirculation of ezetimibe.
about
Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging.Pharmacokinetic non-interaction analysis in a fixed-dose formulation in combination of atorvastatin and ezetimibe.Ezetimibe for management of hypercholesterolemia.Pharmacodynamic interaction between the new selective cholesterol absorption inhibitor ezetimibe and simvastatin.Population Pharmacokinetic Modeling of the Enterohepatic Recirculation of Fimasartan in Rats, Dogs, and Humans.Comparative study on solid self-nanoemulsifying drug delivery and solid dispersion system for enhanced solubility and bioavailability of ezetimibe.The Interpretation of Cholesterol Balance Derived Synthesis Data and Surrogate Noncholesterol Plasma Markers for Cholesterol Synthesis under Lipid Lowering TherapiesMethods to evaluate biliary excretion of drugs in humans: an updated review.Efficacy and tolerability of ezetimibe 10 mg/day coadministered with statins in patients with primary hypercholesterolemia who do not achieve target LDL-C while on statin monotherapy: A Canadian, multicentre, prospective study--the Ezetrol Add-On StReduced absorption of saturated fatty acids and resistance to diet-induced obesity and diabetes by ezetimibe-treated and Npc1l1-/- mice.Enterohepatic recirculation model of irinotecan (CPT-11) and metabolite pharmacokinetics in patients with glioma.New insights into the molecular mechanism of intestinal fatty acid absorption.A reappraisal of the risks and benefits of treating to target with cholesterol lowering drugs.Quantitative Assessment of Food Effect on the Pharmacokinetics of Nano-Crystallized Megestrol Acetate.Population pharmacokinetic modelling of the enterohepatic recirculation of diclofenac and rofecoxib in rats.Empirical and semi-mechanistic modelling of double-peaked pharmacokinetic profile phenomenon due to gastric emptying.Novel nanoemulsion for minimizing variations in bioavailability of ezetimibe.Differences in the metabolism and pharmacokinetics of two structurally similar PPAR agonists in dogs: involvement of taurine conjugation.Role of enterohepatic recirculation in drug disposition: cooperation and complications.Interaction of single-dose ezetimibe and steady-state cyclosporine in renal transplant patients.Solitary Inhibition of the Breast Cancer Resistance Protein Efflux Transporter Results in a Clinically Significant Drug-Drug Interaction with Rosuvastatin by Causing up to a 2-Fold Increase in Statin Exposure.Population pharmacokinetic analysis of simvastatin and its active metabolite with the characterization of atypical complex absorption kinetics.Pharmacokinetic interactions and tolerability of rosuvastatin and ezetimibe: an open-label, randomized, multiple-dose, crossover study in healthy male volunteers.Glucuronidation: driving factors and their impact on glucuronide disposition
P2860
Q31015624-0D002862-260B-4814-85B5-2D5002256079Q34579515-B241A073-E1CA-420C-A96B-F55B94705152Q35139242-74F66721-5F6E-4A62-A9D2-890489EF7349Q35804027-C4935202-3667-48EB-9029-3D7BF1748B8EQ35967888-7C3D25B6-B12C-4D52-B835-AD3FAB849C95Q36137372-16D7E6F7-A84C-4B37-AA58-6548A4C9FF0CQ36315691-69348148-B555-4E51-8CAD-F54977623EFBQ36495774-E7B5346A-DAB8-4B40-88DE-16C2E4DAC633Q36940565-E4F38138-DF5D-43B6-8D9E-71657FCB5DA8Q36956106-BB24BC1B-7B54-4100-93FA-D8DB5EA9510CQ37558026-2BA379FA-CE87-4FD4-AC1A-5E5BCC845D63Q37718704-3B85EBB2-1338-40AC-A095-1C333729635CQ38113494-35E16957-4BD0-4A6D-BD13-30A51A7B2CCDQ39379170-E5C33001-B10B-4B10-800E-9C75F29B7F6EQ43075810-DB944596-D3E6-4B3E-90A1-CC14DA9C870DQ43096307-A739715A-6799-46DD-B390-4D3811C43B3AQ43196457-F8D3BC2E-2F11-4E3B-8DA6-24920A4981D8Q45239727-2988F061-C57E-40BA-AC5D-009F876819B9Q46578287-C785033C-EC11-4829-BA3C-9F0151E2174AQ46954385-1ECE706D-952C-466F-B382-56926912322CQ50749129-1C4C72FA-A988-4957-AD4E-14C3CD8D529CQ53295075-78870739-E589-4CC0-9CC5-35A410DFCD0EQ55266025-906D2F2A-2ADC-49E8-BF2C-4728BD4F520DQ56030213-ECB3F79C-CDC5-4E28-B5AB-A90FD395AEF5
P2860
A population pharmacokinetic model that describes multiple peaks due to enterohepatic recirculation of ezetimibe.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
A population pharmacokinetic m ...... ic recirculation of ezetimibe.
@en
A population pharmacokinetic m ...... ic recirculation of ezetimibe.
@nl
type
label
A population pharmacokinetic m ...... ic recirculation of ezetimibe.
@en
A population pharmacokinetic m ...... ic recirculation of ezetimibe.
@nl
prefLabel
A population pharmacokinetic m ...... ic recirculation of ezetimibe.
@en
A population pharmacokinetic m ...... ic recirculation of ezetimibe.
@nl
P2093
P1476
A population pharmacokinetic m ...... ic recirculation of ezetimibe.
@en
P2093
P304
P356
10.1016/S0149-2918(01)80075-8
P577
2001-06-01T00:00:00Z